PubMed:32239591 / 756-856 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T13","span":{"begin":22,"end":30},"obj":"SP_7"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T12","span":{"begin":0,"end":100},"obj":"Sentence"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok133","span":{"begin":0,"end":2},"obj":"CD"},{"id":"tok134","span":{"begin":2,"end":3},"obj":"."},{"id":"tok135","span":{"begin":3,"end":4},"obj":"CD"},{"id":"tok136","span":{"begin":4,"end":5},"obj":"NN"},{"id":"tok137","span":{"begin":5,"end":6},"obj":","},{"id":"tok138","span":{"begin":7,"end":9},"obj":"CD"},{"id":"tok139","span":{"begin":9,"end":10},"obj":"."},{"id":"tok140","span":{"begin":10,"end":11},"obj":"CD"},{"id":"tok141","span":{"begin":11,"end":12},"obj":"NN"},{"id":"tok142","span":{"begin":13,"end":16},"obj":"CC"},{"id":"tok143","span":{"begin":17,"end":18},"obj":"CD"},{"id":"tok144","span":{"begin":18,"end":19},"obj":"."},{"id":"tok145","span":{"begin":19,"end":20},"obj":"CD"},{"id":"tok146","span":{"begin":20,"end":21},"obj":"NN"},{"id":"tok147","span":{"begin":22,"end":28},"obj":"NNP"},{"id":"tok148","span":{"begin":28,"end":30},"obj":"CD"},{"id":"tok149","span":{"begin":31,"end":39},"obj":"NNS"},{"id":"tok150","span":{"begin":40,"end":43},"obj":"VBD"},{"id":"tok151","span":{"begin":44,"end":52},"obj":"VBD"},{"id":"tok152","span":{"begin":53,"end":59},"obj":"NNS"},{"id":"tok153","span":{"begin":60,"end":62},"obj":"IN"},{"id":"tok154","span":{"begin":63,"end":66},"obj":"NNP"},{"id":"tok155","span":{"begin":66,"end":67},"obj":","},{"id":"tok156","span":{"begin":68,"end":71},"obj":"NNP"},{"id":"tok157","span":{"begin":72,"end":75},"obj":"CC"},{"id":"tok158","span":{"begin":76,"end":85},"obj":"NN"},{"id":"tok159","span":{"begin":85,"end":86},"obj":","},{"id":"tok160","span":{"begin":87,"end":99},"obj":"RB"},{"id":"tok161","span":{"begin":99,"end":100},"obj":"."},{"id":"lookup20","span":{"begin":4,"end":5},"obj":"percent"},{"id":"lookup21","span":{"begin":11,"end":12},"obj":"percent"},{"id":"lookup22","span":{"begin":20,"end":21},"obj":"percent"},{"id":"lookup23","span":{"begin":68,"end":71},"obj":"organization"},{"id":"event8","span":{"begin":44,"end":52},"obj":"OCCURRENCE"},{"id":"event14","span":{"begin":40,"end":59},"obj":"STATE"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}

{"project":"LitCovid-PD-MONDO-v1","denotations":[{"id":"T11","span":{"begin":22,"end":30},"obj":"Disease"},{"id":"T12","span":{"begin":63,"end":66},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005103"},{"id":"A13","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0006097"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}

{"project":"MeasurableQuantitativeAnnotation","denotations":[{"id":"E1","span":{"begin":43,"end":65},"obj":"entity"},{"id":"E2","span":{"begin":67,"end":70},"obj":"entity"},{"id":"E3","span":{"begin":75,"end":84},"obj":"entity"},{"id":"N2","span":{"begin":6,"end":10},"obj":"num"},{"id":"N3","span":{"begin":16,"end":19},"obj":"num"},{"id":"U1","span":{"begin":3,"end":4},"obj":"unit"},{"id":"U2","span":{"begin":10,"end":11},"obj":"unit"},{"id":"U3","span":{"begin":19,"end":20},"obj":"unit"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}

{"project":"Inflammaging","denotations":[{"id":"T12","span":{"begin":0,"end":100},"obj":"Sentence"},{"id":"T12","span":{"begin":0,"end":100},"obj":"Sentence"}],"text":"31.6%, 35.4% and 5.1% COVID-19 patients had elevated levels of ALT, AST and bilirubin, respectively."}